A new trading day began on Monday, with Alto Neuroscience Inc (NYSE: ANRO) stock price down -6.78% from the previous day of trading, before settling in for the closing price of $3.98. ANRO’s price has ranged from $3.88 to $24.00 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -50.00%. Meanwhile, its annual earnings per share averaged 72.85%. With a float of $22.18 million, this company’s outstanding shares have now reached $26.88 million.
The extent of productivity of a business whose workforce counts for 63 workers is very important to gauge. In terms of profitability, gross margin is 22.31%, operating margin of -14572.58%, and the pretax margin is -13388.44%.
Alto Neuroscience Inc (ANRO) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Alto Neuroscience Inc is 17.74%, while institutional ownership is 68.18%. The most recent insider transaction that took place on Jul 09 ’24, was worth 152,085. In this transaction CHIEF MEDICAL OFFICER of this company bought 12,069 shares at a rate of $12.60, taking the stock ownership to the 36,920 shares. Before that another transaction happened on Jul 10 ’24, when Company’s CHIEF MEDICAL OFFICER bought 2,931 for $13.22, making the entire transaction worth $38,748. This insider now owns 39,851 shares in total.
Alto Neuroscience Inc (ANRO) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.66 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 72.85% per share during the next fiscal year.
Alto Neuroscience Inc (NYSE: ANRO) Trading Performance Indicators
Here are Alto Neuroscience Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 19.85.
Technical Analysis of Alto Neuroscience Inc (ANRO)
The latest stats from [Alto Neuroscience Inc, ANRO] show that its last 5-days average volume of 0.58 million was superior to 0.36 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 0.83%. Additionally, its Average True Range was 0.97.
During the past 100 days, Alto Neuroscience Inc’s (ANRO) raw stochastic average was set at 0.22%, which indicates a significant decrease from 0.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 487.10% in the past 14 days, which was higher than the 208.04% volatility it showed in the past 100 days.
Now, the first resistance to watch is $3.91. This is followed by the second major resistance level at $4.10. The third major resistance level sits at $4.22. If the price goes on to break the first support level at $3.60, it is likely to go to the next support level at $3.48. The third support level lies at $3.29 if the price breaches the second support level.
Alto Neuroscience Inc (NYSE: ANRO) Key Stats
With a market capitalization of 102.33 million, the company has a total of 26,959K Shares Outstanding. Currently, annual sales are 0 K while annual income is -36,310 K. The company’s previous quarter sales were 0 K while its latest quarter income was -16,030 K.
